|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Breast cancer
Real-World Evidence of Trastuzumab, Pertuzumab, and Docetaxel Combination as a First-Line Treatment for Korean Patients with HER2-Positive Metastatic
Breast Cancer
Yong-Pyo Lee, Min-Sang Lee, HongSik Kim, Ji-Yeon Kim, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park
Cancer Res Treat.
2022;54(4):1130-1137. Published online January 17, 2022 DOI:
https://doi.org/10.4143/crt.2021.1103
Cited By 1
Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced
Breast Cancer
: A Single-Institutional Clinical Experience
Ji-Yeon Kim, Seok Jin Nam, Jeong Eon Lee, Jonghan Yu, Byung Joo Chae, Se Kyung Lee, Jai Min Ryu, Jin Seok Ahn, Young-Hyuck Im, Seok Won Kim, Yeon Hee Park
Cancer Res Treat.
2022;54(4):1091-1098. Published online January 10, 2022 DOI:
https://doi.org/10.4143/crt.2021.901
Cited By 5
Fear of Cancer Recurrence and Its Negative Impact on Health-Related Quality of Life in Long-term
Breast Cancer
Survivors
Thi Xuan Mai Tran, So-Youn Jung, Eun-Gyeong Lee, Heeyoun Cho, Na Yeon Kim, Sungkeun Shim, Ho Young Kim, Danbee Kang, Juhee Cho, Eunsook Lee, Yoon Jung Chang, Hyunsoon Cho
Cancer Res Treat.
2022;54(4):1065-1073. Published online December 8, 2021 DOI:
https://doi.org/10.4143/crt.2021.835
Cited By 8
Clinicopathological Characterization of Double Heterozygosity for
BRCA1
and
BRCA2
Variants in Korean
Breast Cancer
Patients
Yoon Ju Bang, Won Kyung Kwon, Seok Jin Nam, Seok Won Kim, Byung-Joo Chae, Se Kyung Lee, Jai Min Ryu, Jong-Won Kim, Jonghan Yu, Jeong Eon Lee
Cancer Res Treat.
2022;54(3):827-833. Published online October 13, 2021 DOI:
https://doi.org/10.4143/crt.2021.791
Cited By 1
Effect of Postoperative Radiotherapy after Primary Tumor Resection in De Novo Stage IV
Breast Cancer
: A Multicenter Retrospective Study (KROG 19-02)
Yeon Joo Kim, Yeon-Joo Kim, Yong Bae Kim, Ik Jae Lee, Jeanny Kwon, Kyubo Kim, Jihye Cha, Myungsoo Kim, In Young Jo, Jung Hoon Kim, Jaehyeon Park, Jin Hee Kim, Juree Kim, Kyung Hwan Shin, Su Ssan Kim
Cancer Res Treat.
2022;54(2):478-487. Published online July 12, 2021 DOI:
https://doi.org/10.4143/crt.2021.632
Cited By 3
β1,4-Galactosyltransferase V Modulates
Breast Cancer
Stem Cells through Wnt/β-catenin Signaling Pathway
Wei Tang, Meng Li, Xin Qi, Jing Li
Cancer Res Treat.
2020;52(4):1084-1102. Published online May 27, 2020 DOI:
https://doi.org/10.4143/crt.2020.093
Cited By 7
Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive
Breast Cancer
: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis
Ying Lin, Mingxi Lin, Jian Zhang, Biyun Wang, Zhonghua Tao, Yiqun Du, Sheng Zhang, Jun Cao, Leiping Wang, Xichun Hu
Cancer Res Treat.
2020;52(4):1059-1066. Published online April 24, 2020 DOI:
https://doi.org/10.4143/crt.2019.633
Cited By 14
RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative
Breast Cancer
Tian-Hao Weng, Min-Ya Yao, Xiang-Ming Xu, Chen-Yu Hu, Shu-Hao Yao, Yi-Zhi Liu, Zhi-Gang Wu, Tao-Ming Tang, Pei-Fen Fu, Ming-Hai Wang, Hang-Ping Yao
Cancer Res Treat.
2020;52(3):973-986. Published online April 22, 2020 DOI:
https://doi.org/10.4143/crt.2019.726
Cited By 11
Detection of Germline Mutations in
Breast Cancer
Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test
Hee-Chul Shin, Han-Byoel Lee, Tae-Kyung Yoo, Eun-Shin Lee, Ryong Nam Kim, Boyoung Park, Kyong-Ah Yoon, Charny Park, Eun Sook Lee, Hyeong-Gon Moon, Dong-Young Noh, Sun-Young Kong, Wonshik Han
Cancer Res Treat.
2020;52(3):697-713. Published online February 4, 2020 DOI:
https://doi.org/10.4143/crt.2019.559
Cited By 21
PIK3CA
H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative
Breast Cancer
Patients Treated with Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
Sanxing Guo, Sibylle Loibl, Gunter von Minckwitz, Silvia Darb-Esfahani, Bianca Lederer, Carsten Denkert
Cancer Res Treat.
2020;52(3):689-696. Published online February 4, 2020 DOI:
https://doi.org/10.4143/crt.2019.497
Cited By 20
Prevalence of
PALB2
Germline Mutations in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan
Muhammad Usman Rashid, Faiz Ali Khan, Noor Muhammad, Asif Loya, Ute Hamann
Cancer Res Treat.
2019;51(3):992-1000. Published online October 11, 2018 DOI:
https://doi.org/10.4143/crt.2018.356
Cited By 7
Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers
Eun-Gyeong Lee, Hyok Jo Kang, Myong Cheol Lim, Boyoung Park, Soo Jin Park, So-Youn Jung, Seeyoun Lee, Han-Sung Kang, Sang-Yoon Park, Boram Park, Jungnam Joo, Jai Hong Han, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat.
2019;51(1):280-288. Published online May 4, 2018 DOI:
https://doi.org/10.4143/crt.2018.079
Cited By 6
Psychosocial Health of Disease-Free
Breast Cancer
Survivors Compared with Matched Non-cancer Controls
Boyoung Park, Moo Hyun Lee, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat.
2019;51(1):178-186. Published online April 5, 2018 DOI:
https://doi.org/10.4143/crt.2017.585
Cited By 4
Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic
Breast Cancer
Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
In Hae Park, Seock-Ah Im, Kyung Hae Jung, Joo Hyuk Sohn, Yeon Hee Park, Keun Seok Lee, Sung Hoon Sim, Kyong-Hwa Park, Jee Hyun Kim, Byung Ho Nam, Hee-Jun Kim, Tae-Yong Kim, Kyung-Hun Lee, Sung-Bae Kim, Jin-Hee Ahn, Suee Lee, Jungsil Ro
Cancer Res Treat.
2019;51(1):43-52. Published online February 14, 2018 DOI:
https://doi.org/10.4143/crt.2017.562
Cited By 30
Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic
Breast Cancer
Renaud Sabatier, Véronique Diéras, Xavier Pivot, Etienne Brain, Henri Roché, Jean-Marc Extra, Audrey Monneur, Magali Provansal, Carole Tarpin, François Bertucci, Patrice Viens, Christophe Zemmour, Anthony Gonçalves
Cancer Res Treat.
2018;50(4):1226-1237. Published online December 28, 2017 DOI:
https://doi.org/10.4143/crt.2017.446
Cited By 6
Evaluation of the Benefit of Radiotherapy in Patients with Occult
Breast Cancer
: A Population-Based Analysis of the SEER Database
Byoung Hyuck Kim, Jeanny Kwon, Kyubo Kim
Cancer Res Treat.
2018;50(2):551-561. Published online June 1, 2017 DOI:
https://doi.org/10.4143/crt.2017.189
Cited By 9
Clinically Significant Unclassified Variants in
BRCA1
and
BRCA2
Genes among Korean
Breast Cancer
Patients
Kyong-Ah Yoon, Boyoung Park, Byung Il Lee, Moon Jung Yang, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat.
2017;49(3):627-634. Published online September 13, 2016 DOI:
https://doi.org/10.4143/crt.2016.292
Cited By 10
An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative
Breast Cancer
In Hae Park, Joo Hyuk Sohn, Sung Bae Kim, Keun Seok Lee, Joo Seop Chung, Soo Hyeon Lee, Tae You Kim, Kyung Hae Jung, Eun Kyung Cho, Yang Soo Kim, Hong Suk Song, Jae Hong Seo, Hun Mo Ryoo, Sun Ah Lee, So Young Yoon, Chul Soo Kim, Yong Tai Kim, Si Young Kim, Mi Ryung Jin, Jungsil Ro
Cancer Res Treat.
2017;49(3):569-577. Published online September 12, 2016 DOI:
https://doi.org/10.4143/crt.2016.289
Cited By 55
Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic
Breast Cancer
in Korea
Seung Hoon Beom, Jisu Oh, Tae-Yong Kim, Kyung-Hun Lee, Yaewon Yang, Koung Jin Suh, Hyeong-Gon Moon, Sae-Won Han, Do-Youn Oh, Wonshik Han, Tae-You Kim, Dong-Young Noh, Seock-Ah Im
Cancer Res Treat.
2017;49(2):454-463. Published online August 23, 2016 DOI:
https://doi.org/10.4143/crt.2016.259
Cited By 1
Improving Conventional or Low Dose Metronomic Chemotherapy with Targeted Antiangiogenic Drugs
Robert S. Kerbel
Cancer Res Treat.
2007;39(4):150-159. Published online December 31, 2007 DOI:
https://doi.org/10.4143/crt.2007.39.4.150
Cited By 37
A Locally Advanced
Breast Cancer
with Difficult Differential Diagnosis of Carcinosarcoma and Atypical Medullary Carcinoma, which had Poor Response to Adriamycin- and Taxane-based Neoadjuvant Chemotherapy: A Case Report
Se Hyun Kim, Hyun Cheol Chung, Jaeheon Jeong, Ji Hoon Kim, Sun Young Rha, Joong Bae Ahn, Nam Hoon Cho, Hei-Cheul Jeung
Cancer Res Treat.
2007;39(3):134-137. Published online September 30, 2007 DOI:
https://doi.org/10.4143/crt.2007.39.3.134
Cited By 3
Effects of the Expression of Leptin and Leptin Receptor (OBR) on the Prognosis of Early-stage
Breast Cancer
s
Yongnam Kim, Si-Young Kim, Jae Jin Lee, Jeongho Seo, Youn-Wha Kim, Suck Hwan Koh, Hwi-Joong Yoon, Kyung Sam Cho
Cancer Res Treat.
2006;38(3):126-132. Published online June 30, 2006 DOI:
https://doi.org/10.4143/crt.2006.38.3.126
Cited By 11
Serum HER2 as a Response Indicator to Various Chemotherapeutic Agents in Tissue HER2 Positive Metastatic
Breast Cancer
Sun-Young Kong, Do Hoon Lee, Eun Sook Lee, Susan Park, Keun Seok Lee, Jungsil Ro
Cancer Res Treat.
2006;38(1):35-39. Published online February 28, 2006 DOI:
https://doi.org/10.4143/crt.2006.38.1.35
Cited By 11
Expression of Cyclooxygenase-2 in Human
Breast Cancer
: Relationship with HER-2/neu and other Clinicopathological Prognostic Factors
Eunmi Nam, Soon Nam Lee, Seock-Ah Im, Do-Yeun Kim, Kyoung Eun Lee, Sun Hee Sung
Cancer Res Treat.
2005;37(3):165-170. Published online June 30, 2005 DOI:
https://doi.org/10.4143/crt.2005.37.3.165
Cited By 5
The Differential Gene Expression Profiles between Sensitive and Resistant
Breast Cancer
Cells to Adriamycin by cDNA Microarray
Myung-Ju Ahn, Ki-Hwan Lee, Joon-Ik Ahn, Dong-Hyun Yu, Hye-Sook Lee, Jung-Hye Choi, Joung Soon Jang, Jong Min Bae, Yong-Sung Lee
Cancer Res Treat.
2004;36(1):43-49. Published online February 29, 2004 DOI:
https://doi.org/10.4143/crt.2004.36.1.43
Cited By 8
Korean
Breast Cancer
Data of 1997
J Korean Cancer Assoc.
1999;31(6):1202-1209.
Prognostic Significance of Occult Lymph Node Metastases in
Breast Cancer
Won Cheol Park, Kyoung Keun Lee, Kwong Man Lee, Ki Jung Yun
J Korean Cancer Assoc.
1999;31(6):1195-1201.
The Predictors of Axillary Node Metastasis in 2 cm or Less
Breast Cancer
Han Sung Kang, Dong Young Noh, Oh Joong Kwon, Yeo Kyu Youn, Seung Keun Oh, Kuk Jin Choe
J Korean Cancer Assoc.
1999;31(6):1188-1194.
Effect of Adjuvant Chemotherapy of Operable
Breast Cancer
: Survival and Prognostic Factor Analysis
Jeong Gyun Kim, Tae Won Kim, Je Hwan Lee, Sung Bae Kim, Cheolwon Suh, Kyoo Hyung Lee, Jung Shin Lee, Sei Hyun Ahn, Hyesook Chang, Sang Hee Kim, Woo Kun Kim
J Korean Cancer Assoc.
1999;31(5):1018-1026.
Study on the Apoptosis in Human Prostate and
Breast Cancer
Cells
Eun Jeong Kwon, Myung Sun Lee
J Korean Cancer Assoc.
1999;31(4):728-738.
1
2
3
4
Journal Impact Factor 4.6